Sangamo Therapeutics, Inc.: Sangamo Therapeutics and Voyager

Sangamo Therapeutics, Inc.: Sangamo Therapeutics and Voyager Therapeutics Enter License Agreement for Epigenetic Regulation Treatment of Prion Disease

Sangamo Therapeutics, Inc.: Sangamo Therapeutics and Voyager Therapeutics Enter License Agreement for Epigenetic Regulation Treatment of Prion Disease

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Andrew Funderburk , Alfredw Sandrock Jr , Louise Wilkie , Sandy Macrae , Neurocrine Biosciences , Novartis , Sangamo Therapeutics Inc , Exchange Commission , Voyager Therapeutics Inc , Linkedin , Twitter , Pfizer Inc , Nasdaq , Sangamo Therapeutics , Voyager Therapeutics , Chief Executive Officer , Tropism Redirection , Cell Type Specific Expression , Annual Report , Quarterly Report , Private Securities Litigation Reform Act , Relations Media Inquiries , Peg Rusconi ,